Funding The Future: Accelerating The Long Walk To Innovation
Good ideas must be paired with good people
Executive Summary
In Vivo spoke with two company creators working in the biotech industry about their strategies for seeking new science and their funding philosophy when building the biotechs of tomorrow.
You may also be interested in...
Vaccitech Prepares For IPO, But AZ COVID-19 Vaccine Safety Fears Cloud Launch
The UK biotech aims to raise $100m, but will need to tackle safety concerns to secure a long-term future.
Coming Of Age: Pharma’s Influencer Marketing Matures
Influencer marketing has emerged as a potent tool for many industries and is a sector set to be worth $22bn in its own right by 2025.
Building Out A Blockbuster Franchise: AstraZeneca’s Growth Plans For US Lung Cancer Therapy
Arun Krishna reveals portfolio plans for best-selling therapy Tagrisso, and its other activities to prevent, screen and diagnose lung cancer faster.